Europe Finance Weekly
SEE OTHER BRANDS

Fresh finance and banking news from Europe

Europe Finance Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Europe Finance Weekly.

Press releases published on June 23, 2025

Colle AI Expands Template Integration for Faster NFT Customization

Colle AI Expands Template Integration for Faster NFT Customization

New modular design system empowers creators with rapid customization and multichain-ready asset deployment LONDON, LONDON , UNITED KINGDOM, June 23, 2025 /⁨EINPresswire.com⁩/ -- Colle AI (COLLE), the AI-powered multichain NFT creation platform, has …

Winwinpay Executive Team Concludes iFX EXPO Cyprus with Major Industry Momentum

Winwinpay Executive Team Concludes iFX EXPO Cyprus with Major Industry Momentum

LONDON, UNITED KINGDOM, June 23, 2025 /⁨EINPresswire.com⁩/ -- Hot on the heels of its Simplified Account launch, Winwinpay’s leadership team, CEO David Aldridge, CPO John Stewart, and Senior Sales Director John Wilson, attended the prestigious iFX EXPO …

Press Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-eligible newly diagnosed multiple myeloma

Press Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-eligible newly diagnosed multiple myeloma

Sarclisa recommended for EU approval by the CHMP to treat transplant-eligible newly diagnosed multiple myeloma Recommendation based on GMMG-HD7 phase 3 study demonstrating that Sarclisa with VRd induction treatment significantly improved MRD negativity …

Communiqué de presse : Sarclisa recommandé pour approbation dans l’UE par le CHMP pour le traitement du myélome multiple nouvellement diagnostiqué chez les patients éligibles à une greffe

Communiqué de presse : Sarclisa recommandé pour approbation dans l’UE par le CHMP pour le traitement du myélome multiple nouvellement diagnostiqué chez les patients éligibles à une greffe

Sarclisa recommandé pour approbation dans l’UE par le CHMP pour le traitement du myélome multiple nouvellement diagnostiqué chez les patients éligibles à une greffe Recommandation fondée sur l’étude de phase 3 GMMG-HD7, qui a montré que l’ajout de Sarclisa …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service